Castle Biosciences

Castle Biosciences develops and commercializes diagnostic and prognostic tests for cancers that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.

Year Established: 2007 Stock Ticker: CSTL Exchange: NASDAQ

Locations